Clinical trial · Observational
Pan-Canadian Lung Cancer Observational Study (PALEOS)
NCT04706754CI-TRIAL-00092973recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A multicenter, ambispective observational study focusing on patients diagnosed with lung cancer in Canada identified after January 1, 2000 inclusive. This data will be combined with that from deceased patients identified.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaires | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Prospective
- description
- Adults aged 18 years or older having a documented lung cancer diagnosis since 2000.
- interventionNames
- Other: Questionnaires
Primary outcomes (2)
- measure
- Treatment effectiveness
- timeFrame
- Patients will be followed for at least 5 years, for a total of 25 years
- description
- * To report on the natural history of multiple subgroups of lung cancer patients (regardless of stage) in Canada, from 2000 onwards, using a combination of retrospective and prospective methods that includes diagnostic, molecular alterations, treatment, and outcomes. * To report the real-world treatment patterns of all and specific subgroups of lung cancer patients in Canada, across time (from 2000 onwards), geography. * To recruit from centres that are representative of Canadian patients seen in both academic and community cancer settings.
- measure
- Outcome of Patients
- timeFrame
- Patients will be followed for at least 5 years, for a total of 25 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: • Adults aged 18 years or older having a documented lung cancer diagnosis since 2000. Exclusion Criteria: • Patients that decline to provide informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.